One in Five US Orphan Drug Designations This Month Goes to Korean Firms
Three of 14 therapeutics designated as US FDA orphan drugs this month were developed by Korean firms Yuhan, ABL Bio, and Xcellomol, boosting technology export prospects.
Briefing on user experience design trends, UX research developments, and product design best practices. For product and design teams.
Curated AI briefing - Updates with new content
Create your own AI-powered briefing on any topic — delivered automatically.
You might also enjoy these briefings
Track educational technology news, AI in learning developments, and edtech...
Follow corporate governance news, regulatory filings, and business law...
Briefing on financial regulations, banking compliance news, and fintech...
Briefing on university news, higher education research, and academic policy...
Enjoyed this briefing? Get it delivered to your inbox!
Create Free Account